Shares of Zymeworks Inc. (NYSE:ZYME – Get Free Report) have received a consensus rating of “Hold” from the seven brokerages that are presently covering the firm, Marketbeat reports. Four research analysts have rated the stock with a hold recommendation and three have issued a buy recommendation on the company. The average 12 month target price […]